(Q27851676)

13 November 2016

title

IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome (English)

1 reference

PubMed

13 November 2016

1 reference

acute myeloid leukemia

0 references

myelodysplastic syndrome

1 reference

Jiang Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Dong-ming Yao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Jun Qian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Qin Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Wei Qian

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Yun Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Jing Yang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Cui-zhu Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Hai-yan Chai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Zhen Qian

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Gao-fei Xiao

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

Wen-rong Xu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

14 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21997850

14 December 2024

publication date

April 2012

0 references

14 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21997850

full work available at URL

14 December 2024

http://link.springer.com/content/pdf/10.1007/s00277-011-1352-7.pdf

1 reference

https://api.crossref.org/works/10.1007/S00277-011-1352-7

http://link.springer.com/article/10.1007/s00277-011-1352-7/fulltext.html

14 December 2024

file format

HyperText Markup Language

1 reference

https://api.crossref.org/works/10.1007/S00277-011-1352-7

http://link.springer.com/content/pdf/10.1007/s00277-011-1352-7

14 December 2024

1 reference

https://api.crossref.org/works/10.1007/S00277-011-1352-7

14 December 2024

0 references

91

0 references

issue

4

0 references

page(s)

519-25

0 references

cites work

Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

COLD PCR HRM: a highly sensitive detection method for IDH1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Refractory thrombocytopenia, an unusual myelodysplastic syndrome with an initial presentation mimicking idiopathic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1352-7

ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia

21 January 2018

16

1 reference

https://api.crossref.org/works/10.1007/S00277-011-1352-7

The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia

14 December 2024

17

1 reference

https://api.crossref.org/works/10.1007/S00277-011-1352-7

Rapid detection of JAK2 V617F mutation using high-resolution melting analysis with LightScanner platform

14 December 2024

20

1 reference

https://api.crossref.org/works/10.1007/S00277-011-1352-7

14 December 2024

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017